✦ LIBER ✦

Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

✍ Scribed by V. Diehl; M. Pfreundschuh; M. Löffler; U. Rühl; E. Hiller; H. Gerhartz; W. Wilmanns; H. Kirchner; W. Schoppe; S. Petsch; H. Bartels; K. H. Pflüger; J. Teichmann; R. Fuchs; G. Kühn; W. Oertel; R. Mertelsmann; T. Hecht; K. P. Schalk; P. Worst; M. Wilhelmy; W. Gassmann; U. Loos; R. Hinterberger; H. Theml; T. Wagner; S. Samandari; W. Schäfgen; J. Preiss; G. Schmitz; W. Mende; B. Mödder; H. D. Schick

Book ID: 112962911
Publisher: Springer US
Year: 1989
Tongue: English
Weight: 598 KB
Volume: 6
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02985239

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serial pulmonary function studies in chi

Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine

✍ Neyssa M. Marina; Carol A. Greenwald; Dr. Diane L Fairclough; Elizabeth I. Thomp 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Intensified Chemotherapy and Dose-Reduce

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

✍ Eich, H. T.; Diehl, V.; Gorgen, H.; Pabst, T.; Markova, J.; Debus, J.; Ho, A.; D 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 166 KB

Intensified Chemotherapy and Dose-Reduce

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

✍ Eich, H. T.; Diehl, V.; Gorgen, H.; Pabst, T.; Markova, J.; Debus, J.; Ho, A.; D 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 166 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

Risk-Adapted Therapy With Three or Six C

Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study

✍ Santiago Pavlovsky; Claudia Corrado; Miguel A. Pavlovsky; María V. Prates; Lucía 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 127 KB